Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  van Zyl Smit, Richard N ^a   Binder, Anke ^a   Meldau, Richard ^a   Mishra, Hridesh ^b   Semple, Patricia L ^a   Theron, Grant ^a   Peter, Jonathan ^a   Whitelaw, Andrew ^c   Sharma, Suren K ^b   Warren, Robin ^d   Bateman, Eric D ^a   Dheda, Keertan ^a,c,e  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d STELLENBOSCH UNIVERSITY   (South Africa)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE; UNCLASSIFIED DRUG; URACIL H 3;

ACCURACY; AGAR MEDIUM; ANALYTIC METHOD; ANALYTICAL PARAMETERS; ARTICLE; BACTERIAL COUNT; BACTERIAL LOAD; CLINICAL RESEARCH; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; DILUTION; DYNAMIC RANGE; ISOTOPE LABELING; LABORATORY AUTOMATION; LIMIT OF DETECTION; LIQUID CULTURE; LUCIFERASE REPORTER CONSTRUCT BIOLUMINESCENCE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RELATIVE DISCRIMINATIVE ABILITY; REPRODUCIBILITY; TURNAROUND TIME; ISOLATION AND PURIFICATION; LUMINESCENCE; METHODOLOGY;

COLONY COUNT, MICROBIAL; LUMINESCENCE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION;

EID: 84055207496     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028815     Document Type: Article

References (27)

1. Dheda K, van Zyl-Smit R, Badri M, Pai M, (2009) T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med 15: 188-200.
2. Pai M, Kalantri S, Dheda K, (2006) New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn 6: 423-432.
3. Urdea M, Penny LA, Olmsted SS, Giovanni MY, Kaspar P, et al. (2006) Requirements for high impact diagnostics in the developing world. Nature 444 (Suppl 1): 73-79.
4. Dheda K, Shean K, Zumla A, Badri M, Streicher EM, et al. (2010) Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Lancet 375: 1798-1807.
5. Dheda K, Warren RM, Zumla A, Grobusch MP, (2010) Extensively Drug-resistant Tuberculosis: Epidemiology and Management Challenges. Infectious disease clinics of North America 24: 705-725.
6. Akhtar M, Bretzel G, Boulahbel D, Dawson DA, Fattorini L, et al. (2000) Sputum Examination for Tuberculosis by Direct Microscopy in Low Income Countries.
7. Ritchie SR, Harrison AC, Vaughan RH, Calder L, Morris AJ, (2007) New recommendations for duration of respiratory isolation based on time to detect Mycobacterium tuberculosis in liquid culture. European Respiratory Journal 30: 501-507.
8. Skinner MA, Ramsay AJ, Buchan GS, Keen DL, Ranasinghe C, et al. (2003) A DNA prime-live vaccine boost strategy in mice can augment IFN-γ responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis. Immunology 108: 548-555.
9. Fremond CM, Togbe De, Doz E, Rose S, Vasseur V, et al. (2007) IL-1 Receptor-Mediated Signal Is an Essential Component of MyD88-Dependent Innate Response to Mycobacterium tuberculosis Infection. The Journal of Immunology 179: 1178-1189.
10. Snewin VA, Gares M-P, Gaora PO, Hasan Z, Brown IN, et al. (1999) Assessment of Immunity to Mycobacterial Infection with Luciferase Reporter Constructs. Infect Immun 67: 4586-4593.
11. Freeman S, Post FA, Bekker LG, Harbacheuski R, Steyn LM, et al. (2006) Mycobacterium tuberculosis H37Ra and H37Rv differential growth and cytokine/chemokine induction in murine macrophages in vitro. Journal of interferon & cytokine research: the official journal of the International Society for Interferon and Cytokine Research 26: 27-33.
12. Pheiffer C, Carroll NM, Beyers N, Donald P, Duncan K, et al. (2008) Time to detection of Mycobacterium tuberculosis in BACTEC systems as a viable alternative to colony counting. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease 12: 792-798.
13. Diacon AH, Maritz JS, Venter A, van Helden PD, Andries K, et al. (2010) Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology 29: 1561-1565.
14. Hesseling AC, Walzl G, Enarson DA, Carroll NM, Duncan K, et al. (2010) Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease 14: 560-570.
15. Dheda K, Huggett JF, Bustin SA, Johnson MA, Rook G, et al. (2004) Validation of housekeeping genes for normalizing RNA expression in real-time PCR. Biotechniques 37: 112-114, 116, 118-119.
16. Dheda K, Huggett JF, Chang JS, Kim LU, Bustin SA, et al. (2005) The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization. Anal Biochem 344: 141-143.
17. Greco S, Rulli M, Girardi E, Piersimoni C, Saltini C, (2009) Diagnostic accuracy of in-house PCR for pulmonary tuberculosis in smear-positive patients: meta-analysis and metaregression. Journal of clinical microbiology 47: 569-576.
18. Blakemore R, Story E, Helb D, Kop J, Banada P, et al. (2010) Evaluation of the analytical performance of the Xpert MTB/RIF assay. Journal of clinical microbiology 48: 2495-2501.
19. Helb D, Jones M, Story E, Boehme C, Wallace E, et al. (2010) Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. Journal of clinical microbiology 48: 229-237.
20. Kampmann B, Gaora PO, Snewin VA, Gares MP, Young DB, et al. (2000) Evaluation of human antimycobacterial immunity using recombinant reporter mycobacteria. The Journal of Infectious Diseases 182: 895-901.
21. Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, et al. (2011) Evaluation of the Xpert(R) MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting. American journal of respiratory and critical care medicine.
22. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, et al. (2010) Rapid molecular detection of tuberculosis and rifampin resistance. The New England journal of medicine 363: 1005-1015.
23. Hellyer TJ, Fletcher TW, Bates JH, Stead WW, Templeton GL, et al. (1996) Strand displacement amplification and the polymerase chain reaction for monitoring response to treatment in patients with pulmonary tuberculosis. The Journal of Infectious Diseases 173: 934-941.
24. Thomsen VO, Kok-Jensen A, Buser M, Philippi-Schulz S, Burkardt HJ, (1999) Monitoring treatment of patients with pulmonary tuberculosis: can PCR be applied? Journal of clinical microbiology 37: 3601-3607.
25. O'Sullivan DM, Sander C, Shorten RJ, Gillespie SH, Hill AVS, et al. (2007) Evaluation of liquid culture for quantitation of Mycobacterium tuberculosis in murine models. Vaccine 25: 8203-8205.
26. Zhang T, Li SY, Converse PJ, Almeida DV, Grosset JH, et al. (2011) Using bioluminescence to monitor treatment response in real time in mice with Mycobacterium ulcerans infection. Antimicrobial agents and chemotherapy 55: 56-61.
27. Andrew PW, Roberts IS, (1993) Construction of a bioluminescent mycobacterium and its use for assay of antimycobacterial agents. J Clin Microbiol 31: 2251-2254.